Flexigesic

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flexigesic

Quick Facts

Property Description
Active ingredient Diclofenac (often combined with Paracetamol and Chlorzoxazone)
Form Tablet (Oral administration)
Pharmacological class Non-steroidal anti-inflammatory drug (NSAID) combination
Common use Symptomatic relief of pain, inflammation, and muscle spasm
Origin Synthetic compound

What Type of Medicine is Flexigesic? (Identity and Classification)

Flexigesic is a synthetic compound that primarily contains Diclofenac, which is a Non-steroidal anti-inflammatory drug (NSAID) and a Phenylacetic acid derivative. Unlike some single-ingredient Diclofenac formulations, Flexigesic is commonly recognized as a combination product that features other active ingredients, such as the general Analgesic Paracetamol (Acetaminophen) and Chlorzoxazone, a centrally acting muscle relaxant. This multi-component structure is a distinctive factor, positioning the medicine to address complex symptoms involving both pain and muscle spasm simultaneously.

Composition and Available Preparations (Form and Structure)

Flexigesic is predominantly available as an Oral Tablet, which utilizes a pharmaceutical Base/vehicle to deliver its combined active ingredients for systemic effect. The inclusion of Diclofenac, Paracetamol, and Chlorzoxazone is formulated to provide enhanced Analgesic efficacy for managing acute musculoskeletal discomfort. This combination targets three aspects of discomfort: inflammation, general pain, and muscle stiffness, reflecting a specific application strategy rather than a generic anti-inflammatory approach.

Flexigesic's General Purpose (High-Level Benefit)

The general therapeutic objective of Flexigesic is to provide effective symptomatic relief of pain and inflammation often compounded by muscle spasms. The use of Diclofenac in combination with a muscle relaxant like Chlorzoxazone is used in managing acute musculoskeletal disorders where both anti-inflammatory action and muscle relaxation are necessary. This integrated approach is intended to restore mobility and alleviate the acute discomfort stemming from tissue injury and resulting muscle tightness.

What side effects are possible with Flexigesic?

Possible Side Effects and Safety Information

Flexigesic, a combination product containing Diclofenac, Paracetamol, and Chlorzoxazone, has a safety profile established by the regulatory labeling of its components. Adverse reactions are classified by frequency and system-organ class, as is standard in regulatory documentation.


Common Adverse Reactions and Organ Systems

Commonly documented adverse reactions primarily involve the Gastrointestinal system, often presenting as nausea, vomiting, abdominal pain, or diarrhea. Nervous system disorders such as dizziness, headache, and drowsiness are also commonly reported, often noted more frequently early in the course of treatment due to the muscle relaxant component.


Serious Adverse Reactions and Risk Factors

The labeling details several serious adverse reactions. These include a risk of serious cardiovascular thrombotic events (e.g., myocardial infarction, stroke) and serious gastrointestinal events (e.g., bleeding, ulceration, perforation), which are associated with long-term use and higher doses of the NSAID component. Severe hepatic toxicity, including rare cases of liver failure, is also documented, necessitating caution regarding the Hepatobiliary system.


Population-Specific Safety Considerations

Regulatory documents highlight that older adults are at a greater documented risk for serious gastrointestinal events. The medicine is contraindicated in individuals with known hypersensitivity to any of its components or other NSAIDs, and in those with severe organ impairment, specifically severe heart failure or severe hepatic or renal impairment. These safety limitations define the specific conditions under which the medication must not be used.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile of Flexigesic by detailing potential clinical presentations and mandated emergency procedures.

Documented Overdose Presentations

Overdose symptoms can range from mild to severe, often affecting the Central Nervous System (CNS) and the autonomic nervous system.

Common or Minor Effects:

  • Nausea and vomiting
  • Somnolence (extreme sleepiness)
  • Dizziness
  • Agitation or confusion

Severe, Life-Threatening Effects:

  • The development of Serotonin Syndrome, a critical condition characterized by hyperthermia (high body temperature), tachycardia (rapid heart rate), profuse sweating, and severe changes in neuromuscular activity (e.g., tremor, hyperreflexia, rigidity).
  • Seizures or convulsions.
  • Profound CNS depression, leading to coma.

Emergency Response and Treatment Focus

It is critically important to understand that there is no specific antidote available to reverse the effects of a Flexigesic overdose. For this reason, official guidance emphasizes that treatment must be entirely symptomatic and supportive.

Immediate Medical Attention is Required:

Any known or suspected ingestion beyond the prescribed amount must be treated as a medical emergency. You must immediately contact emergency medical services or a poison control center. Prompt intervention is necessary to monitor vital signs and manage potentially fatal complications, particularly Serotonin Syndrome and severe CNS effects.

Therapeutic Uses of Flexigesic

This combination medication is commonly used across conditions presenting with acute episodes of pain and is focused on providing appropriate symptomatic support by generally addressing a cluster of symptoms that may become intense or noticeable in painful musculoskeletal conditions. Its application is relevant in conditions such as soft tissue injuries with spasm, neck and back pain, and inflammation related to conditions like tendinitis and bursitis.

Flexigesic is applied across domains where additional symptomatic support is needed due to inflammation, swelling, and muscle spasms that create noticeable physiological strain arising from soft tissue damage or rheumatic conditions. It is relevant in contexts marked by increased discomfort associated with chronic joint conditions like Osteoarthritis, where it is applied during phases when symptoms become more noticeable. This supportive relief provides support that helps ease the overall symptom burden during symptomatic periods, and it may assist with maintaining a sense of stability when symptoms are more noticeable.

“This medication is commonly used to help with groups of symptoms that cluster into patterns requiring supportive management.”

Quick Fact: Relief for Pain, Spasm, and Inflammation

Category Primary Benefit Focus
Symptom Cluster Pain, Swelling, and Muscle Spasm
Clinical Context Acute Musculoskeletal Flare-ups
Patient Benefit Assists with maintaining a sense of stability and comfort

Regulatory References

  1. Rwanda FDA Prescribing Information (Summary of Products Characteristics)

Eligibility and Restrictions for Use

Who can and cannot use Flexigesic? — Official Regulatory Information

Regulatory documents strictly define the populations that must not use this medicine due to safety risks. Flexigesic is contraindicated for patients with a known hypersensitivity to acetaminophen, ibuprofen, other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or any product components. It is also prohibited for patients who have experienced allergic-type reactions (e.g., asthma, hives) after taking aspirin or other NSAIDs.

Use is contraindicated for treating pain right before or after coronary artery bypass graft (CABG) surgery.

Eligibility Classification Restricted Populations
Contraindicated (Must NOT use) Hypersensitivity or aspirin/NSAID allergy, Peri-operative pain from CABG surgery.
Not Recommended/Avoid Use Patients with renal impairment, Patients with severe hepatic impairment, Patients with a history of stomach ulcers or bleeding.
Specific Restrictions Pregnancy: Not recommended at 20 weeks gestation and later; consult a healthcare professional before use. Pediatric Use: Safety and efficacy have not been established in children under 12 years of age.

Use of Flexigesic in women attempting to conceive should be considered for withdrawal. Patients with heart conditions, such as recent myocardial infarction (MI) or severe heart failure, should avoid use unless a clinician determines the benefits outweigh the significant cardiovascular risks.

What should I know about interactions with other medicines?

Interaction Scope

Medicinal product categories with documented interactions: Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Hepatic Microsomal Enzyme Inducers, Anticoagulants, CNS Depressants, ACE Inhibitors/ARBs/Beta-Blockers, Diuretics, Quinolone Antibiotics, Immunosuppressants, Cardiac Glycosides, Mood Stabilizers.

Interaction-related restrictions: Co-administration with other oral NSAIDs is officially designated as avoided due to the Diclofenac component. Co-administration with Hepatic Microsomal Enzyme Inducers (e.g., Rifampicin) is also to be avoided due to the increased risk of Paracetamol-related toxicity.

Interaction Classifications (High-Level)

Interaction severity classification (as defined in official documents): Interactions are classified across Avoided Risks (Contraindicated Combinations), Increased Toxicity/Risk (e.g., Cyclosporine, Anticoagulants), and Altered Exposure/Efficacy (e.g., Lithium, Diuretics).

Population-specific interaction notes (if applicable): A documented increased risk exists for deterioration of renal function in the elderly, volume-depleted patients, or those with existing renal impairment when combining the Diclofenac component with ACE Inhibitors or ARBs.

Official Interaction Statements

  • The combination with alcohol or other CNS depressants may result in an officially documented additive CNS depressant effect (Chlorzoxazone component).
  • The Diclofenac component may increase the plasma concentrations of Lithium and Digoxin and reduce the therapeutic effect of diuretics and antihypertensive agents.
  • The co-administration of Anticoagulants (e.g., Warfarin) increases the synergistic risk of serious gastrointestinal bleeding.
  • Paracetamol absorption is reduced by Cholestyramine and increased by Metoclopromide, demonstrating pharmacokinetic modification.

Connection to the overall interaction profile (2–4 sentences): Regulatory documents define this product's interaction structure through multiple component-specific mechanisms, detailing both pharmacokinetic and pharmacodynamic constraints. The profile specifies prohibited co-administrations and lists substances that alter drug exposure or diminish the efficacy of co-administered treatments. This structure ensures all formally documented co-administration risks and restrictions are explicitly stated.

Mechanism of Action

How Flexigesic Works

Targeting the COX-2 Pathway

Flexigesic is a small molecule that acts by selectively inhibiting the cyclooxygenase-2 ( COX-2) enzyme . The COX-2 enzyme is responsible for converting arachidonic acid into prostaglandin precursors.


Downstream Molecular Cascade

Inhibition of this enzyme decreases the synthesis of pro-inflammatory prostaglandins ( PGE2 and PGI2). The reduction in these mediators is the immediate biochemical consequence. Specifically, the specific COX-2 blockade limits the PGE2-mediated signaling cascade, which is a key pathway in the inflammatory response.


System-Level Modulation

By modulating the generalized inflammatory cascade through prostaglandin regulation, Flexigesic also modulates the inflammatory microenvironment implicated in osteoclastogenesis (the process of bone resorption). This interaction is a direct physiological consequence of altering local inflammatory signaling pathways.

Dosage and Administration Information

Flexigesic is a fixed-dose combination tablet containing Diclofenac 50 mg, Paracetamol 325 mg, and Chlorzoxazone 250 mg per unit. The official administration route for this medication is oral.

The standard adult dosing regimen involves the administration of one tablet per dose, taken up to two to three times daily. This schedule establishes a defined daily intake for the active components. In line with the pharmacological profile of the Diclofenac component, the tablets are to be taken with or immediately following food to support proper tolerability. The tablet must be swallowed whole using liquid and should not be crushed, chewed, or broken.

The overarching principle of use, common to anti-inflammatory medicines, is that Flexigesic should be utilized at the lowest effective dose for the shortest duration necessary. For certain populations, such as older adults or patients with hepatic or renal impairment, specific caution is advised, and the principle of using the lowest effective dose is emphasized. To manage proper drug levels, users should not administer a double dose to compensate for any missed administration.

Recent Clinical Evidence

Flexigesic: Recent Clinical Evidence

The research base centers on the clinical evaluation conducted with its combination of active ingredients in various musculoskeletal contexts. This information summarizes the structure of the clinical research as reported in official and peer-reviewed sources.


Evidence for Acute Musculoskeletal Pain and Spasm

The primary evidence comes from short-term Randomized Controlled Trials (RCTs) and systematic reviews that have explored the use of the combination in contexts such as acute low back pain and soft tissue injuries. These studies were conducted during periods of increased symptom activity.

Researchers focused on the measurement of outcomes related to pain intensity, daily functioning, and objective indicators of muscle spasm. While the research provides insight into short-term changes, evidence is generally categorized as heterogeneous across different studies. Existing studies provide limited insight into the comparative patterns between this specific combination and single-drug therapy.


Evidence Gaps and Limitations

Research exploring the role of Flexigesic in conditions characterized by fluctuating or episodic manifestations, such as the flare-ups of chronic joint conditions like arthritis, is more limited. The evidence base for this context often involves extrapolation from acute injury studies, and certainty remains low regarding its role in extended management.

Long-term effects are not fully established because the follow-up durations for most published controlled trials were limited, typically lasting only a few days up to a week. Most available research was evaluated in the general adult population experiencing acute musculoskeletal issues. Consequently, data for certain groups remain insufficient, and research does not determine whether an individual will respond similarly.

Comparative evidence is lacking to definitively establish the combination's position relative to simpler, single-ingredient pain relief options.

Key Studies & References

  1. Summary of Product Characteristics (SmPC) for Diclofenac/Paracetamol/Chlorzoxazone Fixed-Dose Combination (FDC)
  2. Efficacy and safety of fixed-dose combinations of NSAIDs and muscle relaxants in acute musculoskeletal pain: a systematic review
  3. Efficacy and tolerability of thiocolchicoside and diclofenac combination versus diclofenac alone in acute lower back pain

Frequently Asked Questions (FAQ)

Common questions about Flexigesic (FAQ)


Q: How quickly can someone expect Flexigesic to start working?

Official drug information suggests that the active ingredients begin absorption quickly after administration. Information from clinical trials involving similar combinations suggests that onset of effects is often described as occurring within 30 minutes to an hour. The full therapeutic benefit may be reached after this initial period.


Q: What are the most commonly reported side effects of Flexigesic?

Commonly reported adverse reactions listed in official documents include issues with the digestive system, such as nausea, vomiting, diarrhea, and stomach upset. Nervous system disorders like dizziness, drowsiness, and headache are also frequently noted. These nervous system effects are often reported more frequently early in treatment due to the muscle relaxant component.


Q: How long does the effect of a Flexigesic dose typically last?

The standard adult dosing regimen involves administration up to two to three times daily, a frequency that reflects the typical duration of action. The frequency of the required doses is guided by the duration of the active components.


Q: What does the official product information say about taking Flexigesic long-term?

Regulatory guidance emphasizes that anti-inflammatory medicines should be used at the lowest effective dose for the shortest duration necessary. The labeling indicates that extended use carries documented risks associated with the anti-inflammatory component, which include serious gastrointestinal events like ulcers and bleeding. It is not generally intended for prolonged use.


Q: What happens if someone accidentally takes more Flexigesic than recommended?

Taking a higher than recommended dose may lead to increased side effects and carries a risk of serious adverse reactions, including potential damage to the liver and kidneys. Official sources note that contacting a healthcare professional or a poison control center is necessary in the event of a suspected overdosage.


Q: What official information is available about discontinuing the use of Flexigesic?

The medication is generally intended for short-term use for acute conditions and can typically be discontinued once the symptoms are relieved. For individuals using the medication for a longer period, the regulatory guidance indicates that any change in use or discontinuation should involve consultation with a healthcare professional.


Q: What are the ingredients in Flexigesic besides the main active one?

Flexigesic is a combination tablet containing three distinct active ingredients. These are Diclofenac, an anti-inflammatory drug; Paracetamol (Acetaminophen), a general pain reliever; and Chlorzoxazone, a centrally acting muscle relaxant.


Q: Is Flexigesic the same kind of medicine as Advil or Tylenol?

Flexigesic is a unique fixed-dose combination product. It contains Paracetamol, the same active ingredient as Tylenol. It also contains Diclofenac, which belongs to the same class of medicines (NSAIDs) as Ibuprofen (Advil), plus a muscle relaxant. This three-component structure makes it distinct from both of those single-ingredient products.


Q: Is Flexigesic available over-the-counter in any country?

Official labeling for this specific three-component formulation, which includes both an NSAID and a muscle relaxant, generally classifies it as a prescription-only (Rx) medicine. This classification is standard across many regulatory regions that classify these combinations as requiring professional oversight.


Q: Are generic versions of Flexigesic available?

The active components found in Flexigesic (Diclofenac, Paracetamol, and Chlorzoxazone) are widely available in various generic combination products manufactured by multiple companies. While 'Flexigesic' is a brand name, its active ingredients are common and used in many non-branded formulations.


Q: What makes Flexigesic different from other non-prescription pain relievers?

Flexigesic is a fixed-dose combination intended to target multiple symptoms at once. Unlike typical over-the-counter pain relievers, it combines an anti-inflammatory, a general analgesic, and a centrally acting muscle relaxant. This structure is designed to address pain, inflammation, and muscle spasm simultaneously.


Q: What is the official term for the substance that makes Flexigesic work (active ingredient)?

The official active ingredients are the substances that produce the therapeutic effect. In Flexigesic, these are Diclofenac, Paracetamol (also known as Acetaminophen), and Chlorzoxazone.


Q: Can Flexigesic affect blood pressure readings?

The anti-inflammatory component (Diclofenac) is associated with cardiovascular risk, and regulatory documents note that it can reduce the therapeutic effect of blood pressure medicines (antihypertensives). Regulatory documents indicate that patients with high blood pressure should be managed with caution, as changes in blood pressure are a possibility noted in the Diclofenac labeling.


Q: What type of pain is Flexigesic generally intended to treat?

According to official documentation, Flexigesic is indicated for the symptomatic relief of pain, inflammation, and muscle spasm. This typically relates to acute musculoskeletal disorders, such as soft tissue injuries, sprains, strains, and various types of low back, shoulder, or neck pain.


Q: Are there specific food interactions mentioned in the official labeling for Flexigesic?

Official labeling states the medicine should be taken with or immediately following food to support proper stomach tolerability and reduce the chance of stomach upset. However, there are no specific individual food items, such as grapefruit or dairy, that are listed in regulatory documents as having a significant interaction with this medicine.


Q: Why is Flexigesic sometimes recommended instead of paracetamol (acetaminophen)?

Paracetamol alone treats only pain and fever. Flexigesic is a combination product chosen when a person needs relief from not only pain but also inflammation (from the NSAID) and muscle spasm (from the muscle relaxant). The combination provides a broader therapeutic approach for specific acute conditions.


Q: Does the time of day a person takes Flexigesic matter?

Due to common side effects like dizziness and drowsiness, administration at a time that limits the impact on activities like driving is generally recommended. Some instructions state that taking the medicine at a fixed time each day helps maintain consistent drug levels in the body.


Q: Is it possible to develop a tolerance to Flexigesic over time?

Official information for this combination product is not known to cause addiction or dependency. The primary caution regarding long-term use is related to the risk of serious physical side effects associated with the active components.


Q: Does Flexigesic interact with common fever-reducing medicines?

Co-administration with other pain relievers or fever-reducing medicines is officially identified as a risk in regulatory documents. Regulatory information indicates that combining this medicine with other products containing Paracetamol or other NSAIDs is restricted due to the potential for overdosage or an increased risk of side effects.


Q: Are there certain professional activities where Flexigesic use is cautioned against?

The labeling includes warnings that due to potential side effects like dizziness, drowsiness, and lightheadedness, activities such as driving or operating heavy machinery may need to be avoided until an individual knows how the medicine affects them. This is a standard precaution related to central nervous system effects.


Q: Is it common for people to feel slightly dizzy after taking Flexigesic?

Yes, dizziness, drowsiness, and headache are commonly reported nervous system disorders according to regulatory documents. These effects are often noted to occur more frequently when a person first begins treatment, which is linked to the action of the muscle relaxant component.


Q: Has Flexigesic been studied in clinical trials involving children?

Official regulatory documents state that the safety and efficacy of Flexigesic have not been established in children under 12 years of age. Therefore, regulatory documentation indicates it is not generally recommended for pediatric use.


Q: Is Flexigesic commonly used for headache relief?

Flexigesic is primarily indicated for pain, inflammation, and muscle spasm related to musculoskeletal disorders. The combination’s official use is focused on conditions associated with muscle stiffness, and it is not typically cited in official documents as a specific primary treatment for tension headaches or migraines.

How should Flexigesic be stored and disposed of?

How to Store and Dispose of Flexigesic?

This medication must be stored strictly according to its official labeling to maintain stability and prevent accidental ingestion.

Official Storage Requirements

Constraint Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine in its original, tightly closed container, protecting it from moisture and light.
Security The container must be kept out of the sight and reach of children and pets.
Stability Do not use this medicine after the expiration date printed on the container.

Disposal Instructions

Official regulatory guidelines prioritize using a drug take-back program, which may include authorized mail-back options or drop-off sites, for disposal of all unused, unwanted, or expired medicine. If a take-back program is unavailable and the specific drug is not on the government's official 'flush list,' dispose of it in the household trash only after mixing it with an undesirable substance, such as dirt or used coffee grounds, and placing it in a sealed bag.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flexigesic found in:

A-Z Index: